AIM ImmunoTech Inc.已正式暂停其股权分配协议,并自2026年5月19日起,终止其持续发售计划。这一决定已通过提交给美国证券交易委员会的文件予以确认。
AIM ImmunoTech Inc.已正式暂停其股权分配协议,并自2026年5月19日起,终止其持续发售计划。这一决定已通过提交给美国证券交易委员会的文件予以确认。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.